Exploring nurses’ perceptions of antipsychotic medication side effects: a smallest space analysis

References

• Bannon, W., Jr. (2015). Missing data within a quantitative research study: How to assess it, treat it, and why you should care. Journal of the American Association of Nurse Practitioners, 27, 230–232. doi: 10.1002/2327-6924.12208
   PubMed Web of Science ®Google Scholar
• Barnes, T. R., Paton, C., Cavanagh, M. R., Hancock, E., & Taylor, D. M. (2007). A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin, 33, 1397–1403. doi: 10.1093/schbul/sbm038
   PubMed Web of Science ®Google Scholar
• Charmaz, K. (2006). Constructing grounded theory. London: Sage.
   Google Scholar
• Chouinard, G., & Margolese, H. C. (2005). Manual for the extrapyramidal symptom rating scale (ESRS). Schizophrenia Research, 76, 247–265. doi: 10.1016/j.schres.2005.02.013
   PubMed Web of Science ®Google Scholar
• Coombs, T., Deane, F. P., Lambert, G., & Griffiths, R. (2003). What influences patients’ medication adherence? Mental health nurse perspectives and a need for education and training. International Journal of Mental Health Nursing, 12, 148–152. doi: 10.1046/j.1440-0979.2003.00281.x
   PubMed Web of Science ®Google Scholar
• Dassori, A. M., Miller, A. L., & Weiden, P. J. (2003). The approaches to schizophrenia communication (ASC) tool: Including the patient perspective in treatment. Disease Management & Health Outcomes, 11, 699–708. doi: 10.2165/00115677-200311110-00002
   Google Scholar
• De Hert, M., Cohen, D., Bobes, J., Cetkovich-Bakmas, M., Leucht, S., Ndetei, D. M., & Correll, C. U. (2011). Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry, 10, 138–151. doi: 10.1002/j.2051-5545.2011.tb00036.x
   PubMed Web of Science ®Google Scholar
• De Leeuw, M., Van Meijel, B., Grypdonck, M., & Kroon, H. (2012). The quality of the working alliance between chronic psychiatric patients and their case managers: Process and outcomes. Journal of Psychiatric and Mental Health Nursing, 19, 1–7. doi: 10.1111/j.1365-2850.2011.01741.x
   PubMed Web of Science ®Google Scholar
• Donald, I. (1994). The structure of office workers’ experience of organizational environments. Journal of Occupational and Organizational Psychology, 67, 241–258. doi: 10.1111/j.2044-8325.1994.tb00565.x
   Web of Science ®Google Scholar
• Dott, S. G., Weiden, P., Hopwood, P., Awad, A. G., Hellewell, J. S., Knesevich, J., & Salzman, C. (2001). An innovative approach to clinical communication in schizophrenia: The approaches to schizophrenia communication checklists. CNS Spectrums, 6, 333–338. doi: 10.1017/S1092852900022045
   PubMedGoogle Scholar
• Forsner, T., Hansson, J., Brommels, M., Wistedt, A. A., & Forsell, Y. (2010). Implementing clinical guidelines in psychiatry: A qualitative study of perceived facilitators and barriers. BMC Psychiatry, 10. doi:10.1186/1471-244X-10-8.
   PubMed Web of Science ®Google Scholar
• Foster, J., Barkus, E., & Yavorsky, C. (2006). Understanding and using advanced statistics. London: Sage.
   Google Scholar
• Goff, D. C., Hill, M., & Freudenreich, O. (2010). Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry, 71, 20–26. doi: 10.4088/JCP.9096su1cc.04
   PubMed Web of Science ®Google Scholar
• Gray, R., Wykes, T., Parr, A. M., Hails, E., & Gournay, K. (2001). The use of outcome measures to evaluate the efficacy and tolerability of antipsychotic medication: A comparison of Thorn graduate and CPN practice. Journal of Psychiatric Mental Health Nursing, 8, 191–196. doi: 10.1046/j.1365-2850.2001.00377.x
   PubMedGoogle Scholar
• Guttman, L. (1968). A general nonmetric technique for finding the smallest co-ordinate space for a configuration of points. Psychometrica, 33, 469–506. doi: 10.1007/BF02290164
   Web of Science ®Google Scholar
• Guttman, R., & Greenbaum, C. (1998). Facet theory: Its development and current status. European Psychologist, 3, 13–36.
   Web of Science ®Google Scholar
• Health Workforce Australia. (2014). National health workforce dataset. Retrieved February 22, 2016 from http://www.hwa.gov.au/resources/health-workforce-data
   Google Scholar
• Hebrew University Data Analysis Package (HUDAP) release 8. Israel: Hebrew University of Jerusalem.
   Google Scholar
• Hellewell, J. S. E. (1999). Do we know what matters to our patients? Clear Perspectives: Management Issues in Schizophrenia, 2, 1–4.
   Google Scholar
• Howard, P. B., El-Mallakh, P., Miller, A. L., Rayens, M. K., Bond, G. R., Henderson, K., & Cooley, A. T. (2009). Fidelity to a medication management evidence-based practice in the treatment of schizophrenia. Psychiatric Services, 60, 929–935. doi: 10.1176/ps.2009.60.7.929
   PubMed Web of Science ®Google Scholar
• Hungerford, C., & Fox, C. (2013). Consumer's perceptions of recovery-oriented mental health services: An Australian case-study analysis. Nursing & Health Sciences, 16, 209–215. doi: 10.1111/nhs.12088
   PubMed Web of Science ®Google Scholar
• Kruskal, J., & Wish, M. (1978). Multidimensional scaling. London: Sage.
   Google Scholar
• Larsen, E. B., & Gerlach, J. (1996). Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics. Acta Psychiatric Scandinavia, 93, 381–388. doi: 10.1111/j.1600-0447.1996.tb10664.x
   PubMed Web of Science ®Google Scholar
• Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet, 373, 31–41. doi: 10.1016/S0140-6736(08)61764-X
   PubMed Web of Science ®Google Scholar
• Lieberman, J. A. (2007). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Efficacy, safety and cost outcomes of CATIE and other trials. Journal of Clinical Psychiatry, 68, e04.
   Google Scholar
• Lynn, M. R. (1986). Determination and quantification of content validity. Nursing Research, 35, 382–385. doi: 10.1097/00006199-198611000-00017
   PubMed Web of Science ®Google Scholar
• Mackin, P., Bishop, D. R., & Watkinson, H. M. (2007). A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry, 7. doi:10.1186/1471-244X-7-28.
   PubMed Web of Science ®Google Scholar
• Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., & Shon, S. (2004). Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry, 161, 1334–1349. doi: 10.1176/appi.ajp.161.8.1334
   PubMed Web of Science ®Google Scholar
• Miller, D. D., Caroff, S. N., Davis, S. M., Rosenheck, R. A., McEvoy, J. P., & Saltz, B. L. (2008). Extrapyramidal side-effects of antipsychotics in a randomised trial. British Journal of Psychiatry, 193, 279–288. doi: 10.1192/bjp.bp.108.050088
   PubMed Web of Science ®Google Scholar
• Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012). Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42, 125–147. doi: 10.1017/S003329171100105X
   PubMed Web of Science ®Google Scholar
• Morrison, P., Meehan, T., & Stomski, N. J. (2015a). Living with antipsychotic medication side-effects: The experience of Australian mental health consumers. International Journal of Mental Health Nursing, 24, 253–261. doi: 10.1111/inm.12110
   PubMed Web of Science ®Google Scholar
• Morrison, P., Meehan, T., & Stomski, N. J. (2015b). Australian case managers' perceptions of mental health consumers use of antipsychotic medications and associated side-effects. International Journal of Mental Health Nursing, 24(2), 104–111. doi:10.1111/inm.12118.
   Google Scholar
• Morrison, P., Meehan, T., & Stomski, N. J. (2016). Australian mental health staff response to antipsychotic medication side effects – the perceptions of consumers. Advances in Mental Health, 14, 4–13. doi: 10.1080/18387357.2015.1080651
   Web of Science ®Google Scholar
• Morrison, P., & Stomski, N. J. (2015). Embracing participation in mental health research: Conducting authentic interviews. Qualitative Research Journal, 15, 47–60. doi: 10.1108/QRJ-05-2014-0021
   Web of Science ®Google Scholar
• Mutsatsa, S. H., Joyce, E. M., Hutton, S. B., Webb, E., Gibbins, H., Paul, S., & Barnes, T. R. (2003). Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandanavica, 108, 439–446. doi: 10.1046/j.0001-690X.2003.00193.x
   PubMed Web of Science ®Google Scholar
• Naber, D. (2008). Subjective effects of antipsychotic drugs and their relevance for compliance and remission. EpidemioEpidemiologia e psichiatria sociale, 17, 174–176. doi: 10.1017/S1121189X00001238
   PubMed Web of Science ®Google Scholar
• Nguyen, D., Brakoulias, V., & Boyce, P. (2009). An evaluation of monitoring practices in patients on second generation antipsychotics. Australasian Psychiatry, 17, 295–299. doi: 10.1080/10398560902842519
   PubMed Web of Science ®Google Scholar
• Paton, C., Esop, R., Young, C., & Taylor, D. (2004). Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatrica Scandanavica, 110, 299–305. doi: 10.1111/j.1600-0447.2004.00372.x
   PubMed Web of Science ®Google Scholar
• Polit, D. F., & Beck, C. T. (2006). The content validity index: Are you sure you know what's being reported? Critique and recommendations. Research in Nursing & Health, 29, 489–497. doi: 10.1002/nur.20147
   PubMed Web of Science ®Google Scholar
• Roe, D., & Goldblatt, H. (2009). Why and how people decide to stop taking prescribed psychiatric medication: Exploring the subjective process of choice. Psychiatric Rehabilitation Journal, 33, 38–46. doi: 10.2975/33.1.2009.38.46
   PubMed Web of Science ®Google Scholar
• Rounds, J. B., & Zevron, M. A. (1983). Multidimensional scaling research in vocational psychology. Applied Psychological Measurement, 7, 491–510. doi: 10.1177/014662168300700407
   Web of Science ®Google Scholar
• Saha, S., Chant, D., & McGrath, J. (2007). A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 64, 1123–1131. doi: 10.1001/archpsyc.64.10.1123
   PubMed Web of Science ®Google Scholar
• Schiffman, S., Reynolds, M., & Young, F. (1981). Introduction in multidimensional scaling. Orlando, FL: Academic Press.
   Google Scholar
• Seale, C., Chaplin, R., Lelliott, P., & Quirk, A. (2007). Antipsychotic medication, sedation and mental clouding: An observational study of psychiatric consultations. Social Science in Medicine, 65, 698–711. doi: 10.1016/j.socscimed.2007.03.047
   PubMed Web of Science ®Google Scholar
• Stomski, N. J., Morrison, P., & Meyer, A. (2015). Antipsychotic medication side effect assessment tools: A systematic review. Australian & New Zealand Journal of Psychiatry [Epub Ahead of Print]. doi:10.1177/0004867415608244
   PubMed Web of Science ®Google Scholar
• Taylor, D., Young, C., Esop, R., Paton, C., & Walwyn, R. (2004). Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. British Journal of Psychiatry, 185, 152–156. doi: 10.1192/bjp.185.2.152
   PubMed Web of Science ®Google Scholar
• Weiden, P. J., & Miller, A. L. (2001). Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. Journal of Psychiatric Practice, 7, 41–47. doi: 10.1097/00131746-200101000-00005
   PubMedGoogle Scholar
• Wolters, H. A., Knegtering, H., van den Bosch, R. J., & Wiersma, D. (2009). Effects and side effects of antipsychotic treatment in schizophrenia: Pros and cons of available self-rating scales. Schizophrenia Research, 112, 114–118. doi: 10.1016/j.schres.2009.03.026
   PubMed Web of Science ®Google Scholar